(Q54506942)

30 May 2018

title

Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure (English)

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80018-7

2 October 2023

main subject

heart failure

0 references

myocardial infarction

1 reference

acute myocardial infarction

inferred from title

1 reference

Cardiology and cardiovascular medicine

inferred from title

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80018-7

2 October 2023

author name string

K. Chatterjee

1

1 reference

PubMed ID

6338075

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6338075

2 October 2023

W. W. Parmley

2

1 reference

PubMed ID

6338075

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6338075

2 October 2023

language of work or name

English

0 references

publication date

1 January 1983

1 reference

30 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0735109783800187?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80018-7

https://api.elsevier.com/content/article/PII:S0735109783800187?httpAccept=text/plain

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80018-7

Journal of the American College of Cardiology

2 October 2023

published in

1 reference

30 May 2018

volume

1

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

133-153

1 reference

30 May 2018

Evidence for increased venous tone in chronic congestive heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

The effects of intravenous apresoline (hydralazine) on cardiovascular and renal function in patients with and without congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

THE CIRCULATORY EFFECTS OF INTRAVENOUS PHENTOLAMINE IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Phentolamine and cardiovascular performance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Thermodilution cardiac output determination with a single flow-directed catheter

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Force-velocity relations in mammalian heart muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Afterload mismatch and preload reserve: A conceptual framework for the analysis of ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Comparison of Isovolumic and Ejection Phase Indices of Myocardial Performance in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Assessment of left ventricular function by single plane cineangiographic volume analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Arterial impedance as ventricular afterload

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hydraulic input impedance to aorta and pulmonary artery in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Input Impedance of the Systemic Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Blood Pressure and Flow in the Ascending Aorta of Conscious Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Input impedance of the systemic circulation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Aortic input impedance in normal man: relationship to pressure wave forms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Pressure and flow generated by the left ventricle against different impedances

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Aortic input impedance in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Left ventricular afterload and aortic input impedance: implications of pulsatile blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Aortic input impedance in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Aortic input impedance during nitroprusside infusion. A reconsideration of afterload reduction and beneficial action

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

The role of vasodilator therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Improvement in left ventricular wall motion following nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Nitroglycerin to unmask reversible asynergy. Correlation with post coronary bypass ventriculography.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Mechanisms of beneficial effects of vasodilators and inotropic stimulation in the experimental failing ischemic heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Severity of contraction abnormalities after acute myocardial infarction in man: response to nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

The significance of nitroglycerin-induced changes in ventricular function after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Acute hemodynamic interventions shift the diastolic pressure-volume curve in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effect of pacing-induced ischemia on left ventricular diastolic pressure-volume relations in dogs with coronary stenoses

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Alterations in vasomotor tone in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Cardiocirculatory dynamics in the normal and failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Vasodilator therapy for chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Physiologic basis of vasodilator therapy for heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Plasma norepinephrine in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Concentration of renin in renal venous blood in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Endocrine factors in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Renin relationships in congestive cardiac failure, treated and untreated

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Plasma Renin in Chronic Experimental Heart Failure and during Renal Sodium "Escape" from Mineralocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Improvement of chronic congestive heart-failure by oral captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

The renin-angiotensin-aldosterone system in congestive failure in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Adrenocortical and renal hormonal function in experimental cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

The mechanism of adaptation of left atrial stretch receptors in dogs with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Long-term control of congestive heart failure with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Use of Sublingual Nitroglycerin in Congestive Failure following Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic effects of nitroglycerin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic effects of nitroglycerin ointment in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Nitrate Therapy for Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Oral hydralazine therapy for chronic refractory heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Minoxidil therapy in chronic congestive heart failure: acute plus long-term hemodynamic and clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Salbutamol in cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Haemodynamic effects of nifedipine in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Use of Phentolamine in Acute Myocardial Infarction Associated with Hypertension and Left Ventricular Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Comparison of haemodynamic effects of phentolamine, sodium nitroprusside, and glyceryl trinitrate in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Use of phentolamine in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic effects of trimazosin in patients with left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Reversal by phenylephrine of the beneficial effects of intravenous nitroglycerin in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Enhanced left ventricular performance with phentolamine in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Contrasting effects of dopamine and isoproterenol in experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Reduction of S-T segment elevation with infusion of nitroprusside in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effect of sodium nitroprusside on mortality in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

The relationship between enzymatic and histologic estimates of the extent of myocardial infarction in conscious dogs with permanent coronary occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Randomized controlled trial of vasodilator therapy after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Objective haemodynamic assessment after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic effects of quantitatively varied experimental mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Reduced Systemic Vascular Resistance as Therapy for Severe Mitral Regurgitation of Valvular Origin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Beneficial effects of hydralazine in severe mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Dynamic changes in the canine mitral regurgitant orifice area during ventricular ejection

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic effects of vasodilator agents in dogs with experimental ventricular septal defects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Afterload reduction in the management of postinfarction ventricular septal defect

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Long-term therapy of heart failure with prazosin: a randomized double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Changes in plasma volume and extracellular fluid volume after addition of prazosin to propranolol treatment in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Prazosin and congestive heart failure: short- and long-term therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hydralazine in the management of left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Long-Term Vasodilator Therapy with Trimazosin in Chronic Cardiac Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

AN ESTIMATION OF THE HEPATIC BLOOD FLOW AND SPLANCHNIC OXYGEN CONSUMPTION IN HEART FAILURE.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Hemodynamic and metabolic responses to upright exercise in patients with congestive heart failure. Treatment with nitroglycerin ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Renal effects of nitroprusside and hydralazine in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effect of captopril on renal function in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Prognosis in coronary artery disease. Angiographic, hemodynamic, and clinical factors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

A completed twenty-five-year follow-up study of 200 patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Prognosis in medically-treated coronary artery disease: influence of ejection fraction compared to other parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Results of long-term vasodilator therapy in patients with refractory congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980018-7

7 January 2021

Vasodilator therapy

29

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80018-7

Renal effects of left atrial distension in dogs with chronic congestive heart failure

2 October 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80018-7

Phentolamine and beta-adrenergic receptors

2 October 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80018-7

Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure

2 October 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80018-7

2 October 2023

Identifiers

1 reference

30 May 2018

PubMed ID

6338075

1 reference

30 May 2018